Recent studies demonstrate that lidocaine suppresses ovarian cancer metastasis via inhibition of NaV1.5-mediated EMT and reduces pulmonary metastasis in a murine breast cancer surgical model [18,20]. This evidence concerns the gene SCN5A and breast carcinoma.